Healthcare Sector
Healthcare Market 2020
Brief Overview
The Indian healthcare industry is expected to reach US$ 79 billion in 2012 and US$ 280 billion by 2020, on the back of increasing demand for specialised and quality healthcare facilities.
Further, the hospital services market, which represents one of the most important segment of the Indian healthcare industry, is expected to be worth US$ 81.2 billion by 2015.
Meanwhile, the Indian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 15.3 per cent during 2011-12 to 2013-14, as per Barclays Capital Equity Research report on India Healthcare & Pharmaceuticals.
Market Size
As per the estimations by RNCOS’s research report titled, ‘The Indian diagnostic services market,’ the sector will grow at the compound annual rate of around 26 per cent during 2012-2015, on back of huge investments, fast expansion into tier II and tier III cities, and strong Government support strengthening the healthcare infrastructure in India.
Trends and Investments
The hospital and diagnostic centre in India has attracted foreign direct investment (FDI) worth US$ 1.40 billion, while drugs & pharmaceutical and medical & surgical appliances industry registered FDI worth US$ 9.66 billion and US$ 523.54 million, respectively during April 2000 to June 2012, according to data provided by Department of Industrial Policy and Promotion (DIPP).
Some of the major investments in the sector include: * German manufacturing company Carl Zeiss has established a research and development (R&D) unit and two manufacturing facilities in Electronics City in Bengaluru * The Kerala Institute of Medical Sciences (KIMS) Group has expanded its overseas operations, with the Royal Bahrain Hospital (RBH). KIMS-RBH is Bahrain's first custom-built hospital in the private sector, and it had Bahrain's first operational sleep lab, advanced laser technology for cosmetic surgery, and foetal medicine treatment facilities, among
Brief Overview
The Indian healthcare industry is expected to reach US$ 79 billion in 2012 and US$ 280 billion by 2020, on the back of increasing demand for specialised and quality healthcare facilities.
Further, the hospital services market, which represents one of the most important segment of the Indian healthcare industry, is expected to be worth US$ 81.2 billion by 2015.
Meanwhile, the Indian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 15.3 per cent during 2011-12 to 2013-14, as per Barclays Capital Equity Research report on India Healthcare & Pharmaceuticals.
Market Size
As per the estimations by RNCOS’s research report titled, ‘The Indian diagnostic services market,’ the sector will grow at the compound annual rate of around 26 per cent during 2012-2015, on back of huge investments, fast expansion into tier II and tier III cities, and strong Government support strengthening the healthcare infrastructure in India.
Trends and Investments
The hospital and diagnostic centre in India has attracted foreign direct investment (FDI) worth US$ 1.40 billion, while drugs & pharmaceutical and medical & surgical appliances industry registered FDI worth US$ 9.66 billion and US$ 523.54 million, respectively during April 2000 to June 2012, according to data provided by Department of Industrial Policy and Promotion (DIPP).
Some of the major investments in the sector include: * German manufacturing company Carl Zeiss has established a research and development (R&D) unit and two manufacturing facilities in Electronics City in Bengaluru * The Kerala Institute of Medical Sciences (KIMS) Group has expanded its overseas operations, with the Royal Bahrain Hospital (RBH). KIMS-RBH is Bahrain's first custom-built hospital in the private sector, and it had Bahrain's first operational sleep lab, advanced laser technology for cosmetic surgery, and foetal medicine treatment facilities, among